| |

Precision Medicine Treatment: Gene-Targeting Mesothelioma

ByHolly Zink

Precision Medicine Treatment: Gene-Targeting MesotheliomaA new precision medicine treatment for mesothelioma comes from scientists in Italy.

This form of mesothelioma occurs after asbestos exposure in people with a genetic mutation. The mutation is represented by patients with an inherited cancer syndrome. These patients typically have an even worse prognosis than other mesothelioma patients.

But the Italian team came up with a way to target the mutated gene. This form of treatment is called precision medicine. Precision medicine treatment looks at the genetics of a patient to select a treatment that will work best for them.

Discovery of a DNA Gene Mutation

Malignant pleural mesothelioma is a rare and aggressive cancer caused by exposure to asbestos. Malignant mesothelioma is one of the most aggressive kinds of cancer. It starts on the membranes around organs and can quickly spread to other parts of the body.

There is limited efficacy of available treatments for mesothelioma patients. By the time most people notice symptoms, mesothelioma may already be widespread. Researchers are evaluating new therapeutic approaches. A precision medicine treatment shows promise.

One new approach may be to target an inherited cancer syndrome caused by a hereditary DNA repair gene. Approximately, 10% of mesothelioma patients have this specific DNA gene mutation. Scientists think that individuals with this mutation may inherit a mesothelioma susceptibility.

Aggressive Form of Mesothelioma Responds to Precision Medicine

A new precision medicine treatment comes from the University of Eastern Piedmont. It appears in a recent issue of the European Journal of Cancer. Scientists are searching for new biasing genes that are associated with mesothelioma.

One gene associated with mesothelioma is the BAP1-tumour predisposition syndrome. Individuals exposed to asbestos with this gene have a greater risk of contracting mesothelioma.

Dr. Irma Dianzani and her team used next-generation DNA sequencing from 113 patients with mesothelioma. Over 7% of malignant pleural mesothelioma patients in this study tested positive for the BAP1-tumour gene.

Patients with the cancer-predisposing gene shared a lower asbestos exposure. Those without the gene had significantly higher asbestos exposure.

These data support the idea that patients with the BAP1-tumour gene have a higher risk of mesothelioma after asbestos exposure. Moreover, they support the biological impact of the identified tumor gene.

Mesothelioma Patients with this Gene Mutation may Benefit from Precision Medicine

Genetics is a major focus for mesothelioma researchers around the world. Genes can help doctors better understand individual cancer cases and how best to treat them.

It is well known that asbestos fibers induce DNA damage in human cells. Individuals with cancer mutations in their DNA repair genes are less able to heal after asbestos exposure.

New data on asbestos exposure show that patients with a cancer-predisposing gene seem more susceptible to mesothelioma. This discovery may be exploited for the development of tailored precision medicine treatment.

Patients with mesothelioma and the BAP1-tumour gene may benefit from precision medicine.

Sources:

Sculco, M., La Vecchia, M., Aspesi, A., Pinton, G., Clavenna, M. G., Casalone, E., … & Dianzani, I. (2022). Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment. European Journal of Cancer, 163, 44-54. https://doi.org/10.1016/j.ejca.2021.12.023

Similar Posts

Mesothelioma Still Rising Despite Ban in Ireland
|

Mesothelioma Still Rising Despite Ban in Ireland

ByAlex Strauss

A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

Does Radiotherapy Reduce Mesothelioma Pain?
| |

Does Radiotherapy Reduce Mesothelioma Pain?

ByAlex Strauss

A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

Website Aims to Protect Homeowners from Mesothelioma
|

Website Aims to Protect Homeowners from Mesothelioma

ByAlex Strauss

Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

Ape Virus Shrinks Mesothelioma Tumors in Lab
|

Ape Virus Shrinks Mesothelioma Tumors in Lab

ByAlex Strauss

A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

Mesothelioma Nurses Ready for New Cases in Australia
| | |

Mesothelioma Nurses Ready for New Cases in Australia

ByAlex Strauss

Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

Mesothelioma Victims’ Victory in Pennsylvania
|

Mesothelioma Victims’ Victory in Pennsylvania

ByAlex Strauss

Workers and their families have won a victory in Pennsylvania after the state Supreme Court ruled that they could sue former employers over late-manifesting industrial diseases like mesothelioma. The decision focused on a provision in Pennsylvania’s Workers’ Compensation Act that says workers cannot sue an employer if their occupational disease occurred more than 300 weeks after their on-the-job exposure. While many occupational injuries and diseases occur within weeks or months of exposure to a toxin, asbestos diseases like mesothelioma are a notable exception. Believed to be caused by chronic irritation from inhaled or ingested asbestos fibers, mesothelioma does not usually begin to cause symptoms until at least a decade after exposure. Expressing the opinion of the majority, Supreme Court Justice…